都市激情在线亚洲国产91_欧美日韩国产国语对白_av成人毛片在线免费观看_少妇爆乳无码专区网站_亚洲Aⅴ无码吞精久久AV_亚洲AV毛片一区无码日韩_国产成人精品1024视频网站_最新综艺节目国产精品喷浆_国产在线拍揄自揄视频网站_天天少妇被猛烈进入在线播放

3358288340
CN
CN EN
Breaking News! Kexing Biopharm Teams Up with ANTIV to Develop Oral Antiviral Drugs for COVID-19

Release date:2022 - 02 - 21

Oral COVID-19 Drugs - the Last Piece of the Puzzle

The COVID-19 pandemic, characterized by the high and quick variability of its causative virus (SARS-CoV-2), is still prevalent worldwide. Several variants of the virus have appeared and spread across the world in waves of new outbreaks, causing concern and attracting wide attention. Although vaccination can give a certain degree of protection, it cannot completely prevent the spread of the virus nor effectively treat infected people. This is where the R&D for therapeutic drugs against the disease becomes imperative. Fortunately, several oral anti-COVID-19 drugs have been granted Marketing Authorization or Emergency Use Authorization overseas, while progress has also been made in the field in China.


Kexing Biopharm Joins in the Development of Oral Antiviral Drugs for COVID-19

On February 20, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as Kexing Biopharm) announced that Shenzhen Kexing Pharmaceutical Co., Ltd. (hereinafter referred to as "Shenzhen Kexing"), a wholly-owned subsidiary of Kexing Biopharm, signed the “SHEN 26 Project Cooperation Agreement” (hereinafter referred to as "Cooperation Agreement) with Shenzhen ANTIV pharma Co., Ltd. (hereinafter referred to as "ANTIV") on February 18, 2022. Globally, ANTIV exclusively licenses the intellectual property rights of SHEN 26 obtained or held by it to Shenzhen Kexing, and transfers the subsequent research and development rights, as well as the commercialization rights, to Shenzhen Kexing.

The signing of this Cooperation Agreement marks the acceleration of the Company's layout in innovator drugs, allowing the Company diversified product reserves, enhanced core competitiveness and enriched antiviral pipelines. All these will not only continuously improve the pharmaceutical R&D, manufacturing and sales system, but also promote the sustainable, rapid and sound development of the Company's business.


About SHEN 26

SHEN26 is a SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitor, which can achieve antiviral effects by inhibiting viral nucleic acid synthesis. The laboratory development has already been completed and preclinical pharmaceutical and process development are undergoing. Meanwhile, relevant patent applications have been submitted to China National Intellectual Property Administration.  The SHEN 26 Project has been included in the 2021 Guangdong Provincial Emergency Response Projects for the Prevention and Control of COVID-19 Infection and has become one of the key special projects of the Ministry of Science and Technology of the People’s Republic of China for Public Safety Risk Prevention and Control and Emergency Technology Equipment.


About Kexing BIOPHARM

Kexing Biopharm is an innovative biopharmaceutical enterprise mainly engaged in the R&D, production and sales of recombinant protein therapeutics and microecological agents. We focus on pharmaceutical research in the therapeutic fields of antiviral, oncology, immunology, hematology, digestion and degenerative diseases.which will benefit patients all over the world and help us turn into a leader in high-quality biologicals.

In recent years, we have achieved continued and rapid growth in its business, becoming a leader in the recombinant protein therapeutics industry. Our core products, remained at the forefront of similar varieties in China, have been adopted by over 18,000 sales terminals, including over 6500 hospitals in the provinces, municipalities and regions across China, and accessed into and sold in over 30 countries, including Brazil, Philippinesand Indonesia.


About ANTIV

Shenzhen ANTIV pharma Co., Ltd. is a biopharmaceutical company focusing on the R&D and sales of antiviral drugs, mainly focusing its research on diseases caused by viruses including coronaviruses, human immunodeficiency virus (HIV) and liver viruses, such as COVID-19, AIDS and hepatitis B.

ANTIV has two core members: Prof. Zhang Xumu, the dean of SUSTech Medi-X Pingshan, with main research interests in pharmaceutical chemistry, antitumor and antiviral small-molecule drugs, and green synthesis of chiral drugs; Prof. Guo Deyin, a professor of Zhongshan School of Medicine of Sun Yat-sen University and the president of Virology Division of Chinese Society for Microbiology, with main research interests in the pathogenesis of coronavirus infections and the mechanism of immune responses thereof, viral-vector gene therapy and antiviral drug screening.


狠狠色噜噜狠狠狠狠色综合久 | 我和闺蜜在公车被cao污文 | 爽死你个放荡粗暴小淫货h文 | 国产在线精品99一区不卡 | 国产睡熟迷奷系列精品视频 | www.国产精品.com | 真实国产乱子伦精品一区二区三区 | 国产在线视频福利 | 国模丽丽啪啪一区二区 | 亚洲精品无码久久久久久久久 | 人妻少妇精品视频一区二区三区 | 中文字幕一区二区日韩欧美 | 永久免费的看黄软件app下载 | 夜夜精品视频一区二区 | 男人扎女下面很爽网站 | 97国产精华最好的产品亚洲 | 丰满少妇被猛烈进入毛片 | 亚洲欧洲中文日韩AV无码 | 日韩精品人妻无码视频一区 | 欧美日韩国产无线码一区 | 真实国产乱子伦精品一区二区三区 | 国产WW久久久久久久久久 | 最近2018中文字幕在线高清第一页 | 国产精品v欧美精品v日韩精品 | 色一情一乱一伦一区二区三区日本 | 国产sanji高清在线视频观看 | 国产小视频免费在线观看 | 日本国产一区在线观看 | 成人性三级欧美在线观看 | 久久国产AVJUST麻豆 | 国产午夜精品理论片小yo奈 | 最好看的2018中文字幕电影下载 | 国产亚洲日韩欧又美又粗又猛又爽又黄的视频 | 欧美91精品久久久久网免费 | 欧美人妻中文字幕乱码在线 | 一级做a爰片久久毛片一 | 97无码免费人妻超级碰碰夜夜 | 超碰高清人人爽久久人人 | 精品人妻少妇一级毛片免费 | 欧美精品一线二线三线 | 久久久久亚洲av成人片乱码 |